고려제약, 자사주 1709주 처분

Goryeo Pharma's disposal of 1,709 treasury shares demonstrates strategic capital management and flexible financial positioning within the pharmaceutical sector. This transaction signals the company's proactive approach to optimizing its capital structure and shareholder returns while maintaining market confidence and operational stability.